JAK2 and metabolic dysfunction-associated steatotic liver disease: PTM can mediate NAFLD development by affecting oxidative stress, lactate accumulation, autophagy, insulin resistance, and inflammation, and the major signaling pathways affected include PPAR, AMPK, AKT, and JAK2–STAT3.